A Clinical Pharmacist-led Intervention to Improvement of Irrational Tube Feeding Using a PDCA Model

作者全名："Liu, Dong; Hu, Sixing; Su, Yi"

作者地址："[Liu, Dong] Chongqing Med Univ, Nanchuan Peoples Hosp, Dept Pharm, Chongqing 408400, Peoples R China; [Hu, Sixing] Peoples Hosp ChangShou ChongQing, Dept Pharm, Chongqing 401220, Peoples R China; [Su, Yi] Changshou Dist Maternal & Child Hlth Care Hosp Cho, Dept Pharm, Chongqing 401220, Peoples R China"

通信作者："Su, Y (通讯作者)，Changshou Dist Maternal & Child Hlth Care Hosp Cho, Dept Pharm, Chongqing 401220, Peoples R China."

来源：LATIN AMERICAN JOURNAL OF PHARMACY

ESI学科分类：PHARMACOLOGY & TOXICOLOGY

WOS号：WOS:001155943900003

JCR分区：Q4

影响因子：0.2

年份：2023

卷号：42

期号：11

开始页：2193

结束页：2198

文献类型：Article

关键词：clinical pharmacist; tube feeding; irrational; PDCA; improve

摘要："Upon preliminary investigation, it was discovered that irrational tube feeding was prevalent within our hospital. We conducted an analysis of the underlying causes and implemented corresponding solu-tions through the use of PDCA. Before intervention, 15 clinical departments were found to be experiencing irrational drug administration, with a proportion accounting for 11.20%. After PDCA, only 12 clinical depart-ments were impacted, and the percentage of unreasonable prescriptions for tube feeding decreased to 6.81%, demonstrating a significant decrease in comparison to pre-intervention levels (p < 0.05). The most types of drugs involved in irrational tube feeding before and after PDCA implementation were cardiovascular system drugs, while the majority of dosage forms involved in irrational drugs before and after PDCA implementation were slow-release preparations. In summary, through the PDCA cycle, we have made progress in improving the irrational phenomenon of tube feeding within our hospital, yet there is still room for further improvement."

基金机构：Science and Technology Project of Nanchuan District [Cx202213]

基金资助正文：Acknowledgments. This work was supported by the Science and Technology Project of Nanchuan District (No. Cx202213) -